Literature DB >> 32889625

The endolymphatic sac tumor: challenges in the eradication of a localized disease.

Vittoria Sykopetrites1, Gianluca Piras2, Annalisa Giannuzzi2, Antonio Caruso2, Abdelkader Taibah2, Mario Sanna2.   

Abstract

OBJECTIVE: Identify the critical points that lead to recurrences and lack of radicality in endolymphatic sac tumors (ELSTs). STUDY
DESIGN: Retrospective case study and review of the literature.
SETTING: Tertiary referral center. PATIENTS: Thirteen cases of ELST were included in the study and their preoperative, intraoperative and postoperative data were analyzed and compared to a review of the literature. INTERVENTION(S): Therapeutical. MAIN OUTCOME MEASURE(S): Prevalence of recurrent and residual tumors, comparison to the literature and analysis of ELST characteristics.
RESULTS: Diagnosis was made 26 ± 17 months after the onset of symptomatology, and an ELST was preoperatively suspected in only six cases. At the time of surgery, 10 patients suffered from hearing loss. Preoperative symptoms or audiometry could not predict labyrinth infiltration, although speech discrimination scores were significantly associated with labyrinth infiltration (p = 0.0413). The labyrinth was infiltrated in 8 cases (57.1%), and in 7 cases (46.7%) the tumor eroded the carotid canal, whereas 6 cases (40%) presented an intradural extension. A gross total resection was achieved in 11 cases. There were two residual tumors, one of which because of profuse bleeding, and one recurrence (23.1%). A mean of 22.8% of recurrent or residual tumors are described in the literature based on 242 published cases, in more than half of the cases as a consequence of subtotal tumor resection (STR).
CONCLUSIONS: Recurrence derives mostly from the difficulty to identify the extension of the tumor due to the extensive bone infiltration. Accurate diagnosis and correct preoperative planning, with embolization when possible, will facilitate surgery and avoid STR due to intraoperative bleeding. Long follow-ups are important in order to avoid insidious recurrences.

Entities:  

Keywords:  Endolymphatic sac tumor; Low-grade adenocarcinoma; Temporal bone tumor; Von hippel-lindau disease

Year:  2020        PMID: 32889625     DOI: 10.1007/s00405-020-06323-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  38 in total

Review 1.  Endolymphatic sac tumors: report of three cases.

Authors:  P H Roche; H Dufour; D Figarella-Branger; W Pellet
Journal:  Neurosurgery       Date:  1998-04       Impact factor: 4.654

2.  History of the Endolymphatic Sac: From Anatomy to Surgery.

Authors:  C Eduardo Corrales; Albert Mudry
Journal:  Otol Neurotol       Date:  2017-01       Impact factor: 2.311

3.  Surgical treatment of endolymphatic sac tumor.

Authors:  Zhao-hui Hou; De-liang Huang; Dong-yi Han; Pu Dai; Wie-yen Young; Shi-ming Yang
Journal:  Acta Otolaryngol       Date:  2011-12-27       Impact factor: 1.494

4.  Endolymphatic sac tumors: clinical outcome and management in a series of 9 cases.

Authors:  Ferdinand C A Timmer; Luud J Neeskens; Lund J Neeskens; Frank J A van den Hoogen; Frank J A van de Hoogen; Pieter J Slootweg; Erwin A Dunnebier; Bernard K H Pauw; Bernard H Pauw; Jef J S Mulder; Cor W R J Cremers; Henricus P M Kunst; Dirk P M Kunst
Journal:  Otol Neurotol       Date:  2011-06       Impact factor: 2.311

5.  Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases.

Authors:  D K Heffner
Journal:  Cancer       Date:  1989-12-01       Impact factor: 6.860

6.  The Gruppo Otologico experience of endolymphatic sac tumor.

Authors:  Sami Tanbouzi Husseini; Enrico Piccirillo; Abdelkader Taibah; Carlo T Paties; Tamama Almutair; Mario Sanna
Journal:  Auris Nasus Larynx       Date:  2012-02-10       Impact factor: 1.863

7.  Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications.

Authors:  H Jeffrey Kim; Marygrace Hagan; John A Butman; Martin Baggenstos; Carmen Brewer; Christopher Zalewski; W Marston Linehan; Russell R Lonser
Journal:  Laryngoscope       Date:  2012-10-15       Impact factor: 3.325

8.  Imaging detection of endolymphatic sac tumor-associated hydrops.

Authors:  John A Butman; Edjah Nduom; H Jeffrey Kim; Russell R Lonser
Journal:  J Neurosurg       Date:  2013-03-08       Impact factor: 5.115

9.  Endolymphatic sac tumors: experience of three cases.

Authors:  Pierre-Louis Bastier; Erwan de Mones; Magali Marro; Wael Elkhatib; Valérie Franco-Vidal; Dominique Liguoro; Vincent Darrouzet
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-05       Impact factor: 2.503

10.  Management of primary and recurrent endolymphatic sac tumors.

Authors:  Matthew L Carlson; Joshua J Thom; Colin L Driscoll; David S Haynes; Brian A Neff; Michael J Link; George B Wanna
Journal:  Otol Neurotol       Date:  2013-07       Impact factor: 2.311

View more
  2 in total

Review 1.  Symptoms and clinical features in patients affected by endolymphatic sac tumor: a systematic review and meta-analysis.

Authors:  Federico Maria Gioacchini; Shaniko Kaleci; Giuseppe Chiarella; Pasquale Viola; Davide Pisani; Alfonso Scarpa; Michele Tulli; Annalisa Pace; Giannicola Iannella; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-15       Impact factor: 3.236

2.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear.

Authors:  Ann Sandison
Journal:  Head Neck Pathol       Date:  2022-04-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.